Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2018
The 8th European Lung Cancer Conference
Access to all presentations that took place at ELCC 2018 in Geneva, Switzerland
Presentation Date(s):- Apr 11 - 14, 2018
- Total Presentations: 407
-
+
Immunotherapy and next-generation TKIs: From second to frontline treatment
- Type: Poster Discussion session
- Presentations: 18
- Moderators:P. Garrido Lopez
- Coordinates: 4/12/2018, 07:45 - 09:00, Room A
-
+
134PD - Primary PFS and safety analyses of a randomized phase III study of carboplatin + paclitaxel +/− bevacizumab, with or without atezolizumab in 1L non-squamous metastatic NSCLC (IMpower150)
10:54 - 10:54 | Presenter: M. Reck
- Abstract
Loading... -
+
136PD_PR - 3-year survival and duration of response in randomized phase II study of atezolizumab (atezo) vs docetaxel (doc) in 2L+ NSCLC (POPLAR)
10:54 - 10:54 | Presenter: J. Mazieres
- Abstract
Loading... -
+
137PD - Prognostic factors in oligometastatic non-small-cell lung cancer (OM-NSCLC)
10:54 - 10:54 | Presenter: O. Juan
- Abstract
Loading... -
+
Invited Discussant 134PD, 136PD and 137PD
07:45 - 07:57 | Presenter: P. Garrido Lopez
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
07:57 - 08:07
- Abstract
No abstract available for this presentation
-
+
138PD_PR - Patient-reported outcomes (PROs) in ALEX: A phase III study of alectinib (ALEC) vs crizotinib (CRIZ) in non-small-cell lung cancer (NSCLC)
10:54 - 10:54 | Presenter: M. Perol
- Abstract
Loading... -
+
139PD - Patient-reported outcomes from FLAURA: Osimertinib versus standard of care (SoC) epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) in patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC)
10:54 - 10:54 | Presenter: N. Leighl
- Abstract
Loading... -
+
Invited Discussant 138PD and 139PD
08:07 - 08:17 | Presenter: S. Ekman
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
08:17 - 08:22
- Abstract
No abstract available for this presentation
-
+
140PD - Complex epidermal growth factor receptor (EGFR) mutations and responses to tyrosine kinase inhibitors (TKIs) in advanced lung adenocarcinomas
10:54 - 10:54 | Presenter: B. Zhang
- Abstract
Loading... -
+
141PD - A prospective study of molecular testing status in the EGFR mutation positive NSCLC patients with disease progression during EGFR TKI treatment (REMEDY study)
10:54 - 10:54 | Presenter: K. Kanai
- Abstract
Loading... -
+
142PD - Detection of EGFR mutations in cerebrospinal fluid of EGFR-mutant lung adenocarcinoma with brain metastases
10:54 - 10:54 | Presenter: L. Shi
- Abstract
Loading... -
+
Invited Discussant 140PD, 141PD and 142PD
08:22 - 08:34 | Presenter: S. Ortiz-Cuaran
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
08:34 - 08:44
- Abstract
No abstract available for this presentation
-
+
143PD - Competing central nervous system or systemic progression analysis for patients with EGFR mutation-positive NSCLC receiving afatinib in LUX-Lung 3, 6, and 7
10:54 - 10:54 | Presenter: J.C. Yang
- Abstract
Loading... -
+
144PD - Leptomeningeal metastases in EGFR-mutated non-small cell lung carcinoma: Management after tyrosine kinase inhibitors
10:54 - 10:54 | Presenter: R. Flippot
- Abstract
Loading... -
+
Invited Discussant 143PD and 144PD
08:44 - 08:54 | Presenter: E. Wauters
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
08:54 - 08:59
- Abstract
No abstract available for this presentation
-
+
How can we optimise our organisation to deliver precision oncology?
- Type: Educational session
- Presentations: 5
- Moderators:P. Garrido Lopez
- Coordinates: 4/12/2018, 16:45 - 18:15, Room A
-
+
Organisational models for biomarkers testing
16:45 - 17:05 | Presenter: S. Popat
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Access to personalised medicine
17:05 - 17:25 | Presenter: P. Garrido Lopez
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
The pathologist’s point of view
17:25 - 17:45 | Presenter: F. Lopez-Rios
- Abstract
No abstract available for this presentation
-
+
The patient’s point of view
17:45 - 18:05 | Presenter: S. Novello
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Q&A
18:05 - 18:15
- Abstract
No abstract available for this presentation
-
+
Poster Display session (Friday)
- Type: Poster Display session
- Presentations: 197
- Coordinates: 4/13/2018, 12:30 - 13:00, Hall 1
-
+
209P - The management of brain disease (BD) in ALK-rearranged non-small cell lung cancer (ALK NSCLC): Can systemic treatment delay the initiation of local treatments? Experience of the Ramón y Cajal University Hospital (RyCUH, Madrid)
12:50 - 12:50 | Presenter: R. Martin Huertas
- Abstract
Loading...
